LOVELAND, Colo., Nov. 3, 2016 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a providerof advanced veterinary diagnostic and specialty products, today announced Kevin Wilson, Chief Executive Officer and President, will present at the Canaccord Genuity Medical Technologies & Diagnostics Forum on
The conference will be held at the Westin New York Grand Central, New York, NY on November 17, 2016.
A live webcast of the group presentation will be available at http://wsw.com/webcast/canaccord24/hska. This webcast will be archived for 90 following the live presentation. Management will be available during the day on November 17 for one-on-one meetings. To schedule a one-on-one meeting, please contact Hayden IR at firstname.lastname@example.org.
About HeskaHeska Corporation (NASDAQ:HSKA - News) sells advanced veterinary diagnostic and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, vaccines, local and cloud-based data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The Company's core focus is on supporting veterinarians in the canine and feline healthcare space. For further information on Heska and its products, visit www.heska.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/heska-to-present-at-canaccord-genuity-medical-technologies--diagnostics-forum-on-november-17-300356517.html
SOURCE Heska Corporation
Subscribe to our Free Newsletters!
Endoscopic Retrograde Cholangio-Pancreatography uses endoscopy and fluoroscopic imaging for ...
Wolff-Parkinson-White syndrome is caused due to an extra electrical pathway in the heart, which ...
Discover the amazing health benefits of this ''under-valued'' vegetable called leek. Know the ...View All